BioLine RX Ltd (NASDAQ:BLRX)

1.01
Delayed Data
As of 2:07pm ET
 -0.003 / -0.30%
Today’s Change
0.80
Today|||52-Week Range
1.35
-7.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization318.8K267.7K440.8K483.5K
 
 
 
 
 
 
Operating ExpensesGross Income-318.8K-267.7K-440.8K-483.5K
 
 
 
 
 
General Expenses16.7M16.8M15.7M16.1M
 
 
 
 
 
Research And Development12.0M11.5M11.1M10.8M
 
 
 
 
 
Total Operating Expenses17.0M17.1M16.2M16.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.0M-17.1M-16.2M-16.6M
 
 
 
 
 
Extraordinary Credit1.4M3.4M1.4M207.7K
 
 
 
 
 
Extraordinary Charge-38.1K-105.1K0.00--
 
 
 
Interest Expense On Debt--19.5K15.0K14.0K
 
 
 
 
Other Expenses-2.2M-819.6K-91.0K-1.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.1M-11.0M-14.4M-15.9M
 
 
 
 
 
Net Income-17.1M-11.0M-14.4M-15.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.5M32.4M51.4M56.1M
 
 
 
 
 
Shares To Calculate EPS Diluted22.5M32.4M51.4M56.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.75-$0.33-$0.28-$0.28
 
 
 
 
 
EPS Diluted-$0.75-$0.33-$0.28-$0.28